Issue: fda has requested that the manufacturer of belviq, belviq xr (lorcaserin) voluntarily withdraw the weight-loss drug from the us market because a safety clinical trial shows an increased. Belviq fda. This is an update to the fda drug safety communication: safety clinical trial shows possible increased risk of cancer with weight-loss medicine belviq, belviq xr (lorcaserin) issued on january 14.
belviq fda
Belviq is a federally controlled substance (civ) because it contains lorcaserin hydrochloride and may be abused or lead to drug dependence keep your belviq in a safe place, to protect it from theft never give your belviq to anyone else, because it may cause harm to them selling or giving away this medicine is against the law. The fda asked the maker of weight-loss drug belviq (lorcaserin) to take it off the market after a clinical trial showed an association with an increased risk of cancer.. Belviq affects chemical signals in the brain that control appetite.lorcaserin works by helping you feel full with smaller meals. belviq is used together with diet and exercise to treat obesity.. belviq is sometimes used to treat obesity that may be related to diabetes, high cholesterol, or high blood pressure..
